📰 Intersect Ent Inc News
Page 2 - Intersect Ent Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Intersect Ent Inc. Real-time updates on events, politics, business and more.
June 13, 2022
Welcome to Competition Currents, a monthly newsletter for Greenberg Traurig clients and colleagues highlighting significant recent developments in global antitrust and competition law.
June 10, 2022
StockNews.com started coverage on shares of Intersect ENT (NASDAQ:XENT – Get Rating) in a note issued to investors on Friday. The firm set a “sell” rating on the medical equipment provider’s stock. Intersect ENT stock opened at $28.24 on Friday. The stock has a 50-day moving average of $28.03 and a two-hundred day moving average […]
June 9, 2022
Federal Trade Commission (FTC), Department of Justice (DOJ), U.S. Litigation, Dutch ACM decisions, policies, and market studies, Dutch Courts, UK State of Competition, Antitrust enforcement, Antitrust litigation, Mergers
June 5, 2022
Intersect ENT (NASDAQ:XENT – Get Rating) and LMF Acquisition Opportunities (NASDAQ:LMAO – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings. Profitability This table compares Intersect ENT and LMF […]
June 2, 2022
StockNews.com started coverage on shares of Intersect ENT (NASDAQ:XENT – Get Rating) in a note issued to investors on Thursday. The brokerage set a “sell” rating on the medical equipment provider’s stock. Shares of NASDAQ:XENT opened at $28.24 on Thursday. The firm’s 50 day moving average is $27.99 and its two-hundred day moving average is […]
May 25, 2022
/PRNewswire/ -- Need for reducing the prevalence of chronic sinusitis has expanded the scope of commercialization of minimally invasive devices for sinusitis...
May 25, 2022
Patient's increasing push toward sinus balloon dilation procedures (BSPs) due to better surgical outcomes propelling lucrative opportunities in sinus dilation devices market; rising numbers
May 19, 2022
On May 13, 2022, Medtronic, Inc. announced that it completed the acquisition of Intersect ENT, Inc. The transaction was only able to gain approval of the Federal Trade Commission (FTC)...
May 12, 2022
On Tuesday, the Federal Trade Commission (FTC) issued an order requiring medical device company Medtronic, Inc. to divest Fiagon, a subsidiary of
May 1, 2022
Intersect ENT, Inc. (NASDAQ:XENT – Get Rating) was the recipient of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 2,870,000 shares, a growth of 41.4% from the March 31st total of 2,030,000 shares. Currently, 8.7% of the shares of the company are short […]